December 6, 2011
AURORA, Ontario, December 6, 2011 – The Special Committee of Helix BioPharma Corp. (TSX, NYSE Amex, FSE:
“HBP” or the “Company”) announces that Ernst & Young LLP (“Ernst & Young”) has been engaged to assist the Special
Committee in the investigation of the conduct of certain shareholders and parties related to these shareholders that has come to the attention of the Special Committee. In addition, counsel to the Special Committee has been instructed to commence an application to the Ontario Superior Court of Justice (Commercial List) seeking directions from the Court in relation to the upcoming shareholders’ meeting.